DEPLOYDatabase

Deployment

EksoNR at Germany

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.

EksoNR by Ekso Bionics · Catalog entry · 2 sources · not yet field-verified · Exoskeletons

Track EksoNR at Germany

Recent coverage

See all coverage →

Ekso Bionics maintains a distribution and service facility in Ratingen, Germany to serve the EMEA market. Q1 2026 EMEA revenue was $0.55M with France ($0.21M) and Italy ($0.03M) as reported country breakdowns.

Key facts

EMEA hub
Distribution and service facility in Ratingen, Germany
EMEA revenue Q1 2026
$0.55M (France $0.21M, Italy $0.03M, other EMEA $0.31M)

Exposure

Customer segment
logistics
Scale tier
commercial 10 99

Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Safety record

No incidents on record for EksoNR at Germany.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 2 sources · not yet field-verifiedhow tiers work →
Last updated
2026-08-21
Model
EksoNR
Company
Ekso Bionics
Location
Germany
Operator
Ekso Bionics
Status
operational
Operator type
maker operated
Scale at site
11 to 100 units
Site environment
outdoor
Location precision
verified coordinates
First seen
2024-06-01
ID
31c2725e-115f-4ce4-945d-92d071b713be

Timeline

  1. Jun 2024
    First recorded
    EksoNR first documented operating at Germany.
  2. Jun 2026
    created
  3. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Free to use on your site, with a link back to DEPLOY.

EksoNR operates in Germany. Explore the full verified map:

Sources (2)

  1. https://ir.chronoscale.com/financials-filings/all-sec-filings/content/0001437749-26-013682/0001437749-26-013682.pdf
  2. https://www.eksobionics.com/ekso-nr
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-08-21

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-08-21

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
primary-company-ir
Company IR disclosure
1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for EksoNR at Germany.

Common questions

What is the EksoNR deployment at Germany?
EksoNR, built by Ekso Bionics, is recorded as a deployment at Germany on the DEPLOY registry. Ekso Bionics operates the deployment directly.
Who operates EksoNR at Germany?
Ekso Bionics, the manufacturer of EksoNR, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the EksoNR deployment at Germany go live?
The deployment is recorded as starting June 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the EksoNR deployment at Germany?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces